Key result
Losartan inhibits renal epithelial-mesenchymal transition and oxidative stress via Hsp70 induction in hypertensive rats.
Why the study?
Hypertensive kidney disease research historically focused on afferent arterioles, glomerular damage, and the renin-angiotensin system, but recent evidence implicates tubular cell injury, epithelial-mesenchymal transition, and tubulointerstitial fibrosis, with the Hsp70 chaperone representing a potential therapeutic target.
Does losartan inhibit angiotensin II-induced epithelial-mesenchymal transition and oxidative stress via Hsp70 in hypertensive kidney disease?
Does losartan inhibit angiotensin II-induced epithelial-mesenchymal transition and oxidative stress via Hsp70 in hypertensive kidney disease?
Highlights the cytoprotective role of the Hsp70 chaperone in mediating the renoprotective effects of losartan against angiotensin II-induced tubular epithelial-mesenchymal transition and renal fibrosis in hypertension.
Answers are grounded in this paper and cite their sources.
May inform losartan renoprotection in hypertensive kidney disease via Hsp70; leaves open clinical translation.
Hypertensive nephrosclerosis is the second most common cause of end-stage renal disease after diabetes. For years, hypertensive kidney disease has been focused on the afferent arterioles and glomeruli damage and the involvement of the renin angiotensin system (RAS). Nonetheless, in recent years, novel evidence has demonstrated that persistent high blood pressure injures tubular cells, leading to epithelial–mesenchymal transition (EMT) and tubulointerstitial fibrosis. Injury primarily determined at the glomerular level by hypertension causes changes in post-glomerular peritubular capillaries that in turn induce endothelial damage and hypoxia. Microvasculature dysfunction, by inducing hypoxic environment, triggers inflammation, EMT with epithelial cells dedifferentiation and fibrosis. Hypertensive kidney disease also includes podocyte effacement and loss, leading to disruption of the filtration barrier. This review highlights the molecular mechanisms and histologic aspects involved in the pathophysiology of hypertensive kidney disease incorporating knowledge about EMT and tubulointerstitial fibrosis. The role of the Hsp70 chaperone on the angiotensin II–induced EMT after angiotensin II type 1 receptor (AT1R) blockage, as a possible molecular target for therapeutic strategy against hypertensive renal damage is discussed.
No takes yet. Share an insight, caveat, or question.
Costantino et al. (2021) conducted a review in Hypertensive nephropathy / hypertensive kidney disease. Losartan (via Hsp70 modulation) was evaluated on Angiotensin II-induced epithelial-mesenchymal transition (EMT) and tubulointerstitial fibrosis. Losartan inhibits angiotensin II-induced epithelial-mesenchymal transition and oxidative stress in proximal tubular cells from spontaneously hypertensive rats via the Hsp70 chaperone.
Synapse has enriched 10 related papers. Consider them for comparative context: